T1	Participants 51 107	rectal cancer patients with high preoperative CEA levels
T2	Participants 347 401	122 patients with rectal cancer whose serum CEA levels
T3	Participants 473 536	Patients with preoperative CEA levels <5.0 ng/ml were excluded.